Highlander Capital Management, LLC Zosano Pharma Corp Call Options Transaction History

Highlander Capital Management, LLC

  • $245 Million
  • Q1 2024

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

Others Institutions Holding ZSANQ

# of Institutions
1
Shares Held
28
Call Options Held
0
Put Options Held
0
View Full List

About Zosano Pharma Corp

ZSANQ Quotes by TradingView
  • Ticker ZSANQ
  • Exchange OTC
  • Shares Outstandng 4,902,260
  • Description
  • Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The ...
More about ZSANQ
Track This Portfolio

Track Highlander Capital Management, LLC Portfolio

Follow Highlander Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highlander Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highlander Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email